Ebanga
Product Images NDC 80673-777

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ebanga (NDC 80673-777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ridgeback Biotherapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ebanga 01)

FDA Label Image

Image (Ebanga 02)

Not available.*

FDA Label Image

Principal Display Panel (Kit Carton)

This is a product description for Ebanga, a medication used intravenously. The medication comes in the form of lyophilized imabs. Each vial contains 400mg without preservatives and should be further diluted. The medication does not meet the US Standard of Potency. The code "NDC 8067377701 Rxonly" is present. The text also mentions a website where more information is available.*

FDA Label Image

Principal Display Panel (Kit Carton)

This is a description of a medication called Ebanga (ansuvimab-zykl) that comes in a vial containing 400 mg of the medication to be mixed with other medications for injection to be administered intravenously. The medication comes without preservative, and there is no specified standard for patency. It is monitored, and lot number o000 can be seen on the package. Its NDC number is 80673-777-04, and it can be accessed through ebanga.com. Four boxes containing 36 vials each of 400 mg are included in the package.*

FDA Label Image

Principal Display Panel (Kit Carton)

This is a description of a drug called Ebanga which is used for intravenous use. It comes in powder form in a vial containing 400mg of the drug. It requires further dilution before injection. Each package contains 8 boxes with 36 vials each. The text also includes the drug's National Drug Code (NDC) and website for more information.*

FDA Label Image

Principal Display Panel (400 mg Vial Label)

NDC 80673-001-01 Rx only Ebanga (ansuvimab-glykl) is an injectable medication available in 400mg vials for intravenous use. The medication needs to be reconstituted and diluted before administration, and recommended dosage should be referred to in the prescribing information. Any unused portion of the medication from a single-use vial should be discarded. The medication should be stored at 2°C to 8°C (36°F to 46°F), protected from light, and not frozen or shaken. The manufacturer is Ridgeback Blotherapeutics, LP, located in Miami, FL, and the website is wwwebanga.com.*

FDA Label Image

Principal Display Panel (400 mg Vial Carton)

This is a description of Ansuvimab-zykl, a 400mg powder that requires reconstitution for intravenous use. The package contains 36 vials without preservatives, and the standard of potency is not specified. The NDC 2067300136 number is mentioned along with lot information. The dosage is subject to prescribing information. Instructions are given on the website ebanga.com, and its contact details are also available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.